Michelle Lytle

Michelle Lytle is a principal research scientist at Eli Lilly and Company in Global Regulatory Affairs-CMC. In her current role she is a regulatory scientist responsible for global submissions and control strategy development for biologic products. Michelle holds over 28 years of experience in chemistry, manufacturing and control development in various roles including analytical development, preformulation development and CMC regulatory affairs. In addition to her responsibilities at Lilly, Michelle is an active member of CASSS as an associate director and active member of the Midwest Regional Forum planning committee. Michelle received her B.S. in chemistry from Purdue University in Indianapolis.